Trial watch: Phase III and submission failures: 2007–2010

@article{Arrowsmith2011TrialWP,
  title={Trial watch: Phase III and submission failures: 2007–2010},
  author={John Arrowsmith},
  journal={Nature Reviews Drug Discovery},
  year={2011},
  volume={10},
  pages={87-87}
}
  • John Arrowsmith
  • Published 2011
  • Medicine
  • Nature Reviews Drug Discovery
  • 405 Citations

    Figures and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The Personalized Discovery Process is the only program offering patients treatment recommendations based on an empirically constructed Drosophila "fly" model of their disease… Expand
    ConditionsColon Cancer, Medullary Thyroid Cancer
    InterventionOther
    NEWS ARTICLE
    Animal Experimentation : Working Towards a Paradigm Change
    • 2
    • Highly Influenced
    • PDF
    Innovación tecnológica y financiación de prestaciones
    A hybrid phase I-II/III clinical trial design allowing dose re-optimization in phase III.
    • 2
    • Highly Influenced
    • PDF
    Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer
    The Ethical Implications for Humans in Light of the Poor Predictive Value of Animal Models
    • 8
    • Highly Influenced
    • PDF
    Why is publication of negative clinical trial data important?
    • 12
    • Highly Influenced